Related Experiment Video
Updated: Jun 30, 2026

05:17
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Hard to Halt: Automation Bias in Agent-Driven Sequencing Prior Authorization Workflows.
Medrxiv : the Preprint Server for Health Sciences
|June 29, 2026
Summary
Large language models struggle with prior authorization for genetic sequencing, often submitting incomplete forms. A multi-agent system with human oversight is needed for reliable clinical use in rare disease diagnosis.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Healthcare
- Genomic Medicine
Background:
- Prior authorization (PA) for exome/genome sequencing delays rare disease diagnosis.
- Large language model (LLM)-based browser agents could automate PA workflows.
- Clinical reliability of these agents for PA is uncharacterized.
Purpose of the Study:
- Evaluate LLM-based browser agents for automating prior authorization for exome/genome sequencing.
- Assess clinical reliability in terms of task completion, accuracy, and appropriate withholding of deficient profiles.
Main Methods:
- Developed a simulated payer portal and synthetic EHR with 836 patient records.
- Evaluated Gemini 3 Pro, Gemini 3 Flash, and Claude Opus 4.5 on PA submission tasks.
- Assessed task completion rate, form accuracy, and withholding of deficient profiles.
Main Results:
- Larger models (Gemini 3 Pro, Claude Opus 4.5) had high task completion but failed to withhold deficient profiles.
- Gemini 3 Flash showed better withholding (17.33%) but lower task completion (56.05%).
- Gemini 3 Pro identified 91% of issues in a non-agentic setting, suggesting interaction bias, not reasoning limits.
Conclusions:
- Current LLM browser agents have a bias towards form submission, posing risks in PA workflows.
- A modular, multi-agent architecture with human supervision is crucial for safe clinical deployment.
- Addressing systematic biases is essential for reliable automation of healthcare administrative tasks.
More Related Videos
Related Concept Videos
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Maxam-Gilbert Sequencing
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Challenges of the Maxam-Gilbert Method
The...
Sanger Sequencing
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

